ArticleCureus2025
Assessing Gluten-Induced Brain Fog in a Non-celiac Patient: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While gluten-induced brain fog is frequently reported in individuals with celiac disease, it is uncertain whether people without classic gastrointestinal symptoms of celiac may also experience similar gluten-related cognitive issues. These types of subjective complaints are difficult to quantify in clinical practice, but electroencephalography (EEG) with event-related potentials (ERPs) can be useful in identifying cognitive disturbances. The case we present here is of a 28-year-old male who reported mild cognitive symptoms associated with gluten exposure, not previously objectively evaluated. His evaluation included reaction time, trail-making, and auditory ERP assessments - modalities sensitive to conditions associated with cognition. His initial test was performed after three weeks on a normal gluten-containing diet. After this gluten exposure, the patient reported "brain fog," which was supported by a low P300, the cognitive component of the ERP, even though he still tested strongly in reaction time and trail making. The patient was tested again after three weeks on a gluten-free diet. After eliminating gluten, the patient reported no brain fog, and this was supported by a P300 that was no longer suppressed. While this single case study cannot address causation, the ERP deficits observed in this patient were consistent with the reported "brain fog." Objective modalities such as EEG with P300 can be readily added to the clinical assessment to aid clinicians in testing hypotheses, including situations where elimination diets are considered to address cognitive concerns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.